• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Microwave ablation in solitary hepatocellular carcinoma within 3-5 cm requiring consideration.需要考虑对直径3至5厘米的孤立性肝细胞癌进行微波消融治疗。
Hepatobiliary Surg Nutr. 2023 Aug 1;12(4):622-624. doi: 10.21037/hbsn-23-332. Epub 2023 Jul 14.
2
Repeat hepatectomy versus microwave ablation for solitary and small (≤3 cm) recurrent hepatocellular carcinoma with early or late recurrence: A propensity score matched study.肝切除与微波消融治疗早期或晚期复发的孤立性小（≤3 cm）复发性肝细胞癌的倾向评分匹配研究
Eur J Surg Oncol. 2023 May;49(5):1001-1008. doi: 10.1016/j.ejso.2022.12.016. Epub 2022 Dec 26.
3
Small single perivascular hepatocellular carcinoma: comparisons of radiofrequency ablation and microwave ablation by using propensity score analysis.小的单发性血管周围肝细胞癌：应用倾向评分分析比较射频消融和微波消融
Eur Radiol. 2021 Jul;31(7):4764-4773. doi: 10.1007/s00330-020-07571-5. Epub 2021 Jan 5.
4
Radiation Segmentectomy versus TACE Combined with Microwave Ablation for Unresectable Solitary Hepatocellular Carcinoma Up to 3 cm: A Propensity Score Matching Study.放射性肝段切除术与 TACE 联合微波消融治疗不可切除的 3cm 以下单发肝细胞癌：一项倾向评分匹配研究。
Radiology. 2017 Jun;283(3):895-905. doi: 10.1148/radiol.2016160718. Epub 2016 Dec 7.
5
Microwave vs radiofrequency ablation for hepatocellular carcinoma within the Milan criteria: a propensity score analysis.微波消融与射频消融治疗米兰标准范围内肝细胞癌的疗效比较：倾向评分分析。
Aliment Pharmacol Ther. 2018 Sep;48(6):671-681. doi: 10.1111/apt.14929. Epub 2018 Jul 31.
6
Microwave ablation versus radiofrequency ablation for subcapsular hepatocellular carcinoma: a propensity score-matched study.微波消融与射频消融治疗肝包膜下肝癌：一项倾向评分匹配研究。
Eur Radiol. 2022 Jul;32(7):4657-4666. doi: 10.1007/s00330-022-08537-5. Epub 2022 Jan 29.
7
Evaluation of Medium-Term Efficacy of Y90 Radiation Segmentectomy vs Percutaneous Microwave Ablation in Patients with Solitary Surgically Unresectable < 4 cm Hepatocellular Carcinoma: A Propensity Score Matched Study.Y90 放射性肝段切除术与经皮微波消融治疗<4cm 单发不可切除肝细胞癌的中期疗效评价：倾向评分匹配研究。
Cardiovasc Intervent Radiol. 2021 Mar;44(3):401-413. doi: 10.1007/s00270-020-02712-1. Epub 2020 Nov 23.
8
Microwave ablation shows similar survival outcomes compared with surgical resection for hepatocellular carcinoma between 3 and 5 cm.微波消融治疗 3-5cm 肝癌的生存结果与手术切除相似。
Int J Hyperthermia. 2020 Nov 12;37(1):1345-1353. doi: 10.1080/02656736.2020.1849825.
9
Transarterial chemoembolization combined with microwave ablation versus microwave ablation only for Barcelona clinic liver cancer Stage B hepatocellular carcinoma: A propensity score matching study.经动脉化疗栓塞联合微波消融与单纯微波消融治疗巴塞罗那临床肝癌分期B期肝细胞癌的倾向评分匹配研究。
J Cancer Res Ther. 2020 Sep;16(5):1027-1037. doi: 10.4103/jcrt.JCRT_380_19.
10
Radiofrequency and microwave ablation in combination with transarterial chemoembolization induce equivalent histopathologic coagulation necrosis in hepatocellular carcinoma patients bridged to liver transplantation.在等待肝移植的肝细胞癌患者中，射频和微波消融联合经动脉化疗栓塞诱导出等效的组织病理学凝固性坏死。
Hepatobiliary Surg Nutr. 2016 Jun;5(3):225-33. doi: 10.21037/hbsn.2016.01.05.

引用本文的文献

1
Safety and efficacy analysis of ultrasound-guided microwave ablation for pediatric recurrent aggressive fibromatosis.超声引导下微波消融治疗小儿复发性侵袭性纤维瘤病的安全性与疗效分析
J Orthop Surg Res. 2025 Feb 12;20(1):157. doi: 10.1186/s13018-025-05563-z.

本文引用的文献

1
Atezolizumab plus bevacizumab for patients with Child-Pugh-B in hepatocellular carcinoma.阿替利珠单抗联合贝伐单抗用于Child-Pugh-B级肝细胞癌患者。
Hepatobiliary Surg Nutr. 2022 Dec;11(6):876-878. doi: 10.21037/hbsn-22-432.
2
Precision oncology and molecular therapies for hepatocellular carcinoma.肝细胞癌的精准肿瘤学与分子疗法
Hepatobiliary Surg Nutr. 2022 Dec;11(6):882-885. doi: 10.21037/hbsn-22-458.
3
New developments in ablation therapy for hepatocellular carcinoma: combination with systemic therapy and radiotherapy.肝细胞癌消融治疗的新进展：与全身治疗和放射治疗相结合。
Hepatobiliary Surg Nutr. 2022 Oct;11(5):766-769. doi: 10.21037/hbsn-22-363.
4
Editorial on "".关于“”的社论。
Hepatobiliary Surg Nutr. 2022 Aug;11(4):580-582. doi: 10.21037/hbsn-22-297.
5
Microwave ablation versus laparoscopic resection as first-line therapy for solitary 3-5-cm HCC.微波消融与腹腔镜切除术作为单发 3-5cm HCC 的一线治疗方法。
Hepatology. 2022 Jul;76(1):66-77. doi: 10.1002/hep.32323. Epub 2022 Jan 28.
6
Small single perivascular hepatocellular carcinoma: comparisons of radiofrequency ablation and microwave ablation by using propensity score analysis.小的单发性血管周围肝细胞癌：应用倾向评分分析比较射频消融和微波消融
Eur Radiol. 2021 Jul;31(7):4764-4773. doi: 10.1007/s00330-020-07571-5. Epub 2021 Jan 5.
7
Combined use of microwave ablation and cell immunotherapy induces nonspecific immunity of hepatocellular carcinoma model mice.微波消融联合细胞免疫治疗诱导肝癌模型小鼠非特异性免疫。
Cell Cycle. 2020 Dec;19(24):3595-3607. doi: 10.1080/15384101.2020.1853942. Epub 2020 Dec 7.
8
Cancer statistics, 2020.癌症统计数据，2020 年。
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
9
Long-term outcomes of microwave versus radiofrequency ablation for hepatocellular carcinoma by surgical approach: A retrospective comparative study.手术入路下微波消融与射频消融治疗肝细胞癌的长期疗效：一项回顾性比较研究。
Asian J Surg. 2017 Jul;40(4):301-308. doi: 10.1016/j.asjsur.2016.01.001. Epub 2016 Feb 24.
10
Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial.射频消融联合或不联合经导管动脉化疗栓塞治疗肝细胞癌：一项前瞻性随机试验。
J Clin Oncol. 2013 Feb 1;31(4):426-32. doi: 10.1200/JCO.2012.42.9936. Epub 2012 Dec 26.

Microwave ablation in solitary hepatocellular carcinoma within 3-5 cm requiring consideration.

作者信息

Jiang Lingmin, Liang Chen, Xie Feihu, Zheng Yun

机构信息

Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China.

State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.

出版信息

Hepatobiliary Surg Nutr. 2023 Aug 1;12(4):622-624. doi: 10.21037/hbsn-23-332. Epub 2023 Jul 14.

DOI:10.21037/hbsn-23-332
PMID:37600994
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10432303/
Abstract
摘要